No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Drug Resistance, Neoplasm / genetics
-
Female
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Male
-
Middle Aged
-
Piperazines / therapeutic use*
-
Proto-Oncogene Proteins / genetics*
-
Proto-Oncogene Proteins p21(ras)
-
Pyrimidines / therapeutic use*
-
ras Proteins / genetics*
Substances
-
Antineoplastic Agents
-
Benzamides
-
KRAS protein, human
-
Piperazines
-
Proto-Oncogene Proteins
-
Pyrimidines
-
Imatinib Mesylate
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins